{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:52:13Z","timestamp":1790722333591,"version":"4.1.0"},"reference-count":401,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bone.2021.115935","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T03:43:48Z","timestamp":1616557428000},"page":"115935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Multiple versus solitary giant cell lesions of the jaw: Similar or distinct entities?"],"prefix":"10.1016","volume":"149","author":[{"given":"Willem H.","family":"Schreuder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline E.","family":"van der Wal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0030-4220(53)90151-0","article-title":"Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-oseous) dysplasia of the jawbones","volume":"6","author":"Jaffe","year":"1953","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0030-4220(88)90094-1","article-title":"A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor","volume":"66","author":"Auclair","year":"1988","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0015","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0278-2391(86)90040-6","article-title":"Central giant cell lesions of the jaws: a clinicopathologic study","volume":"44","author":"Chuong","year":"1986","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ajcp\/45.4.437","article-title":"The central giant cell reparative granuloma of the jaws. An analysis of 38 cases","volume":"45","author":"Waldron","year":"1966","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0030-4220(93)90094-K","article-title":"Central giant cell lesions of the jaws. A clinical, radiologic, and histopathologic study","volume":"75","author":"Whitaker","year":"1993","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.bone.2021.115935_bb0030","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0030-4220(59)90215-4","article-title":"Giant-cell reparative granuloma and related conditions affecting the jawbones","volume":"12","author":"Austin","year":"1959","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0278-2391(88)90221-2","article-title":"Central giant cell granuloma of the jaws: experiences in the management of thirty-seven cases","volume":"46","author":"Eisenbud","year":"1988","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2021.115935_bb0040","series-title":"Odontogenic and Maxillofacial Bone Tumours","first-page":"204","author":"El-Naggar","year":"2017"},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0045","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hed.20069","article-title":"Incidence and disease-free survival after surgical therapy of central giant cell granulomas of the jaw in The Netherlands: 1990\u20131995","volume":"26","author":"de Lange","year":"2004","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejmg.2016.05.013","article-title":"Multiple giant cell lesions in a patient with Noonan syndrome with multiple lentigines","volume":"59","author":"van den Berg","year":"2016","journal-title":"Eur. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0055","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ajpath.2019.02.006","article-title":"An overview of the derivation and function of multinucleated giant cells and their role in pathologic processes","volume":"189","author":"Brooks","year":"2019","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1034\/j.1600-0714.2003.00069.x","article-title":"Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw","volume":"32","author":"Itonaga","year":"2003","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/path.1184","article-title":"Phenotypic characterization of mononuclear and multinucleated cells of giant cell reparative granuloma of small bones","volume":"198","author":"Itonaga","year":"2002","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1034\/j.1600-0714.2003.00126.x","article-title":"Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts","volume":"32","author":"Liu","year":"2003","journal-title":"J. Oral Pathol. Med."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb0075","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0278-2391(97)90291-3","article-title":"Markers for macrophage and osteoclast lineages in giant cell lesions of the oral cavity","volume":"55","author":"Tiffee","year":"1997","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/0973-029X.180928","article-title":"Immunohistochemical detection of the receptor activator of nuclear factor Kappa B ligand and c-fos in giant cell granuloma","volume":"20","author":"Ahmed","year":"2016","journal-title":"J. Oral Maxillofac. Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0002-9440(10)64942-5","article-title":"Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation","volume":"156","author":"Huang","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/JOE-11-0212","article-title":"The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorption","volume":"211","author":"Mellis","year":"2011","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb0100","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat. Rev. Genet."},{"issue":"6937","key":"10.1016\/j.bone.2021.115935_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"issue":"43","key":"10.1016\/j.bone.2021.115935_bb0115","doi-asserted-by":"crossref","first-page":"41147","DOI":"10.1074\/jbc.M205063200","article-title":"Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator","volume":"277","author":"Ishida","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.bone.2021.115935_bb0120","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1074\/jbc.M213067200","article-title":"The calcineurin\/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells","volume":"279","author":"Hirotani","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0125","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0130","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1210\/endo-127-6-3111","article-title":"Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts","volume":"127","author":"Bellows","year":"1990","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0135","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1073\/pnas.0406874102","article-title":"Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium\/calcineurin\/NFAT pathway in osteoclasts","volume":"102","author":"Komarova","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0140","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1073\/pnas.0510876103","article-title":"Gain-of-function\/Noonan syndrome SHP-2\/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling","volume":"103","author":"Uhlen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00109-004-0612-6","article-title":"Mechanistic insight into osteoclast differentiation in osteoimmunology","volume":"83","author":"Takayanagi","year":"2005","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"6984","key":"10.1016\/j.bone.2021.115935_bb0150","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.20022220","article-title":"Impaired differentiation of osteoclasts in TREM-2-deficient individuals","volume":"198","author":"Cella","year":"2003","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1359\/JBMR.051016","article-title":"TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function","volume":"21","author":"Humphrey","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20011681","article-title":"A novel member of the leukocyte receptor complex regulates osteoclast differentiation","volume":"195","author":"Kim","year":"2002","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-0714.1974.tb01714.x","article-title":"A histological comparison of the giant cells in the central giant cell granuloma of the jaws and the giant cell tumor of long bone","volume":"3","author":"Abrams","year":"1974","journal-title":"J. Oral Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/his.13249","article-title":"Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart","volume":"71","author":"Mancini","year":"2017","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cjp2.13","article-title":"Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics","volume":"1","author":"Presneau","year":"2015","journal-title":"J. Pathol. Clin. Res."},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb0185","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.13190","article-title":"H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant","volume":"71","author":"Luke","year":"2017","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0195","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1038\/s41467-018-06690-4","article-title":"TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw","volume":"9","author":"Gomes","year":"2018","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.dmfr.4600700","article-title":"Central giant cell granulomas: a systematic review of the radiographic characteristics with the addition of 20 new cases","volume":"31","author":"Stavropoulos","year":"2002","journal-title":"Dento maxillo facial radiology"},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0205","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tripleo.2004.11.015","article-title":"Clinical and radiological features of central giant-cell lesions of the jaw","volume":"99","author":"De Lange","year":"2005","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0210","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0009-9260(89)80325-3","article-title":"Central giant cell granuloma of the jaws: a clinico-radiological study","volume":"40","author":"Horner","year":"1989","journal-title":"Clin. Radiol."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0030-4220(88)90176-4","article-title":"Radiologic features, including those seen with computed tomography, of central giant cell granuloma of the jaws","volume":"65","author":"Cohen","year":"1988","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0220","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S1079-2104(96)80079-5","article-title":"Radiologic features of central giant cell granuloma of the jaws","volume":"81","author":"Kaffe","year":"1996","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0030-4220(87)90115-0","article-title":"Central giant cell lesions of the mandible and maxilla: a clinicopathologic and cytometric study","volume":"64","author":"Ficarra","year":"1987","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tripleo.2005.02.060","article-title":"Central giant cell granuloma of the jaws: a clinical, radiologic, and histopathologic study of 26 cases","volume":"101","author":"Kruse-Losler","year":"2006","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0235","first-page":"606","article-title":"Oral giant cell granulomas. A clinical and histological study of 129 new cases","volume":"81","author":"Andersen","year":"1973","journal-title":"Acta Pathol. Microbiol. Scand. A"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0240","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SCS.0b013e3181cfa5d5","article-title":"Central giant cell granuloma of the jaws","volume":"21","author":"Nicolai","year":"2010","journal-title":"J. Craniofac. Surg."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijom.2005.03.005","article-title":"Long-term clinical and radiological outcomes of surgical management of central giant cell granuloma of the maxilla","volume":"35","author":"Rawashdeh","year":"2006","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0250","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00256-009-0740-8","article-title":"Central giant cell granuloma of the jaws: clinical and radiological evaluation of 22 cases","volume":"38","author":"Sun","year":"2009","journal-title":"Skeletal Radiol."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb0255","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcms.2010.11.010","article-title":"Treatment of central giant-cell granulomas of the jaws in children: conservative or radical surgical approach?","volume":"39","author":"Theologie-Lygidakis","year":"2011","journal-title":"J. Craniomaxillofac. Surg."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0260","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/joms.2002.33241","article-title":"The surgical treatment of central giant cell granuloma of the mandible","volume":"60","author":"Bataineh","year":"2002","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00001665-199801000-00010","article-title":"Surgical and implantation reconstruction in a patient with giant-cell central reparative granuloma","volume":"9","author":"Becelli","year":"1998","journal-title":"J. Craniofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hed.2880160207","article-title":"Giant cell lesions of the maxilla and paranasal sinuses","volume":"16","author":"Stolovitzky","year":"1994","journal-title":"Head Neck"},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0275","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jcms.2009.04.002","article-title":"Surgical treatment and reconstruction for central giant cell granuloma of the jaws: a review of 18 cases","volume":"37","author":"Tosco","year":"2009","journal-title":"J. Craniomaxillofac. Surg."},{"issue":"11","key":"10.1016\/j.bone.2021.115935_bb0280","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ijom.2006.08.010","article-title":"Management of giant cell lesions","volume":"35","author":"Kaban","year":"2006","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0285","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.tripleo.2009.02.013","article-title":"Central giant cell lesion of the jaw: nonsurgical treatment with calcitonin nasal spray","volume":"107","author":"Allon","year":"2009","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0290","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ijporl.2008.03.016","article-title":"Calcitonin: a non-invasive giant cells therapy","volume":"72","author":"Borges","year":"2008","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0295","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10006-012-0370-5","article-title":"Central giant cell granuloma: treatment with calcitonin, triamcinolone acetonide, and a cystic finding 3 years and 6 months after the primary treatment","volume":"17","author":"da Silva Sampieri","year":"2013","journal-title":"Oral Maxillofac. Surg."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0300","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ijom.2006.03.030","article-title":"Calcitonin therapy in central giant cell granuloma of the jaw: a randomized double-blind placebo-controlled study","volume":"35","author":"de Lange","year":"2006","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0266-4356(93)90168-V","article-title":"Central giant cell granulomas of the jaws regress with calcitonin therapy","volume":"31","author":"Harris","year":"1993","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0310","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/humu.9433","article-title":"Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation","volume":"27","author":"Lietman","year":"2006","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0315","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/moe.2001.119246","article-title":"Rapid growth of giant cell granuloma in pregnancy treated with calcitonin","volume":"92","author":"O\u2019Regan","year":"2001","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0320","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/joms.2003.50129","article-title":"Calcitonin therapy for central giant cell granuloma","volume":"61","author":"Pogrel","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0325","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0278-2391(99)90828-5","article-title":"Calcitonin treatment for central giant cell granulomas of the mandible: report of two cases","volume":"57","author":"Pogrel","year":"1999","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0330","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1597\/10-091","article-title":"Orthopedic and orthodontic treatment in central giant cell granuloma treated with calcitonin","volume":"48","author":"Romero","year":"2011","journal-title":"Cleft Palate Craniofac. J."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0335","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.joms.2014.02.017","article-title":"Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab","volume":"72","author":"Schreuder","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0340","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ijom.2016.02.016","article-title":"Can calcitonin nasal spray reduce the risk of recurrence of central giant cell granuloma of the jaws?","volume":"45","author":"Tabrizi","year":"2016","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0345","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tripleo.2006.05.020","article-title":"Calcitonin nasal spray for treatment of central giant cell granuloma: clinical, radiological, and histological findings and immunohistochemical expression of calcitonin and glucocorticoid receptors","volume":"104","author":"Vered","year":"2007","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0350","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bjoms.2004.08.015","article-title":"Treatment of a central giant cell granuloma with intralesional corticosteroid","volume":"43","author":"Abdo","year":"2005","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0355","doi-asserted-by":"crossref","first-page":"186","DOI":"10.14219\/jada.archive.2001.0153","article-title":"Intralesional corticosteroid injection for treatment of central giant-cell granuloma","volume":"132","author":"Adornato","year":"2001","journal-title":"J. Am. Dent. Assoc."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0360","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1067\/moe.2002.119971","article-title":"Intralesional corticosteroids as an alternative treatment for central giant cell granuloma","volume":"93","author":"Carlos","year":"2002","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0365","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/00016480500468976","article-title":"Oral and intralesional steroid therapy in giant cell granuloma","volume":"126","author":"Comert","year":"2006","journal-title":"Acta Otolaryngol."},{"issue":"11","key":"10.1016\/j.bone.2021.115935_bb0370","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.joms.2010.11.020","article-title":"Management of central giant cell granuloma of mandible using intralesional corticosteroids: case report and review of literature","volume":"69","author":"Ferretti","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0375","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1590\/0103-6440201302196","article-title":"Fine needle aspiration cytology and intralesional steroid injection in a central giant cell granuloma affecting the gingiva: a new clinical approach","volume":"24","author":"Fonseca","year":"2013","journal-title":"Braz. Dent. J."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0380","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5005\/johcd-2-3-65","article-title":"An unusual presentation of a central giant cell granuloma and initial treatment with intralesional corticosteroids: A case report and review of the literature","volume":"2","author":"Graham","year":"2008","journal-title":"J. Oral Health Comm. Dent."},{"issue":"6 Pt 1","key":"10.1016\/j.bone.2021.115935_bb0385","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0901-5027(05)80057-8","article-title":"Local injection of corticosteroids for central giant cell granuloma. A case report","volume":"23","author":"Kermer","year":"1994","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb0390","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0347(200012)22:8<822::AID-HED12>3.0.CO;2-W","article-title":"Treatment of giant cell granuloma of the maxilla with intralesional injection of steroids","volume":"22","author":"Khafif","year":"2000","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0395","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1067\/moe.2001.115721","article-title":"Treatment of a central giant cell lesion of the mandible with intralesional glucocorticosteroids","volume":"91","author":"Kurtz","year":"2001","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0400","first-page":"E98","article-title":"Central giant cell lesion of mandible managed by intralesional triamcinolone injections. A report of two cases and literature review","volume":"14","author":"Mohanty","year":"2009","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb0405","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijom.2010.06.015","article-title":"Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant-cell granuloma in 21 cases","volume":"39","author":"Nogueira","year":"2010","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0410","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0901-5027(05)80620-4","article-title":"Intralesional corticosteroid injection for central giant cell granuloma. A case report","volume":"27","author":"Rajeevan","year":"1998","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0415","first-page":"75","article-title":"Intralesional corticosteroid injection for central giant cell granuloma: a case report and review of the literature","volume":"47","author":"Sezer","year":"2005","journal-title":"Turk. J. Pediatr."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0420","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jcms.2010.10.018","article-title":"Management of a locally invasive central giant cell granuloma (CGCG) of mandible: report of an extraordinary large case","volume":"39","author":"Shirani","year":"2011","journal-title":"J. Craniomaxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0425","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1042-3699(20)30771-8","article-title":"Management of central giant cell lesions. An alternative to surgical therapy","volume":"6","author":"Terry","year":"1994","journal-title":"Oral Maxillofac. Surg. Clin. North Am."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0430","first-page":"572","article-title":"Central giant-cell granuloma - an alternative to surgical therapy","volume":"66","author":"Jacoway","year":"1988","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0435","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000325991","article-title":"Fine needle aspiration biopsy in central giant cell lesion: a report of 3 cases","volume":"50","author":"Vargas","year":"2006","journal-title":"Acta Cytol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0440","first-page":"229","article-title":"Intralesional corticosteroid injection for central giant cell granuloma: an alternative treatment for children","volume":"76","author":"Wendt","year":"2009","journal-title":"J. Dent. Child."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0445","doi-asserted-by":"crossref","first-page":"77e","DOI":"10.1097\/PRS.0b013e31817d5f3d","article-title":"Aggressive central giant cell lesion of the maxilla: surgical management and the use of adjuvant interferon alfa-2a","volume":"122","author":"Baker","year":"2008","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.bone.2021.115935_bb0450","first-page":"170","article-title":"Experience with anti-angiogenic therapy of giant cell granuloma of the facial bones","volume":"15","author":"Collins","year":"2000","journal-title":"Ann. R. Australas. Coll. Dent. Surg."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0455","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ijom.2006.02.011","article-title":"Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: a report of 2 cases","volume":"35","author":"de Lange","year":"2006","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0460","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tripleo.2004.11.024","article-title":"Complications of alpha-interferon therapy for aggressive central giant cell lesion of the maxilla","volume":"100","author":"Goldman","year":"2005","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb0465","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1053\/joms.2002.34975","article-title":"Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws","volume":"60","author":"Kaban","year":"2002","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"6 Pt 1","key":"10.1016\/j.bone.2021.115935_bb0470","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1542\/peds.103.6.1145","article-title":"Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a","volume":"103","author":"Kaban","year":"1999","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0475","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11845-012-0858-x","article-title":"Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases","volume":"182","author":"O\u2019Connell","year":"2013","journal-title":"Ir. J. Med. Sci."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb0480","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.joms.2009.06.042","article-title":"Aggressive central giant cell granuloma of the mandible","volume":"68","author":"Schutz","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2021.115935_bb0485","article-title":"Treatment of central giant cell lesions using bisphosphonates with intralesional corticosteroid injections","volume":"823","author":"Da Silva","year":"2012","journal-title":"Head Face Med"},{"issue":"5 Suppl","key":"10.1016\/j.bone.2021.115935_bb0490","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.joms.2008.12.006","article-title":"Alternative indications for bisphosphonate therapy","volume":"67","author":"Landesberg","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0495","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.joms.2017.09.013","article-title":"Denosumab as a treatment alternative for central giant cell granuloma: a long-term retrospective cohort study","volume":"76","author":"Bredell","year":"2018","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0500","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jcms.2015.04.011","article-title":"A novel approach to the management of a central giant cell granuloma with denosumab: a case report and review of current treatments","volume":"43","author":"Gupta","year":"2015","journal-title":"J. Craniomaxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0505","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jbm4.10010","article-title":"Improvement of giant cell lesions of the jaw treated with high and low doses of denosumab: a case series","volume":"1","author":"Kim","year":"2017","journal-title":"JBMR Plus"},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0510","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/j.oooo.2015.07.011","article-title":"Aggressive giant cell lesion of the jaws: a review of management options and report of a mandibular lesion treated with denosumab","volume":"120","author":"O\u2019Connell","year":"2015","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb0515","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.joms.2017.03.013","article-title":"Hyperparathyroidism diagnosed due to brown tumors of the jaw: a case report and literature review","volume":"75","author":"Brabyn","year":"2017","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"9684","key":"10.1016\/j.bone.2021.115935_bb0520","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0525","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0196-0709(96)90075-7","article-title":"Brown tumor of the mandible","volume":"17","author":"Keyser","year":"1996","journal-title":"Am. J. Otolaryngol."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb0530","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ijom.2017.04.013","article-title":"Multiple central giant cell tumour lesions are exclusively linked to syndromes related to RAS\/MAPK pathway anomalies","volume":"46","author":"van den Berg","year":"2017","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0535","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0278-2391(96)90449-8","article-title":"Cherubism in a patient with Noonan\u2019s syndrome","volume":"54","author":"Addante","year":"1996","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb0540","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ejhg.2009.44","article-title":"SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions","volume":"17","author":"Beneteau","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0545","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/1096-8628(20010122)98:3<230::AID-AJMG1080>3.0.CO;2-K","article-title":"Are Noonan syndrome and Noonan-like\/multiple giant cell lesion syndrome distinct entities?","volume":"98","author":"Bertola","year":"2001","journal-title":"Am. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0550","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0030-4220(93)90069-G","article-title":"Multiple central giant cell lesions with a Noonan-like phenotype","volume":"76","author":"Betts","year":"1993","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0555","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12105-010-0178-2","article-title":"Giant cell lesions in noonan syndrome: case report and review of the literature","volume":"4","author":"Bufalino","year":"2010","journal-title":"Head Neck Pathol."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0560","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5005\/jcdp-8-4-67","article-title":"Giant cell lesions with a Noonan-like phenotype: a case report","volume":"8","author":"Cancino","year":"2007","journal-title":"J. Contemp. Dent. Pract."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0565","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/jhg.2013.118","article-title":"A new mutation in the C-SH2 domain of PTPN11 causes Noonan syndrome with multiple giant cell lesions","volume":"59","author":"Carapito","year":"2014","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bone.2021.115935_bb0570","first-page":"14","article-title":"A new syndrome simulating the Noonan syndrome, the Leopard syndrome, and hyperparathyroidism","volume":"2","author":"Cohen","year":"1974","journal-title":"Syndr. Ident."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0575","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0030-4220(89)90012-1","article-title":"The Noonan syndrome\/cherubism association","volume":"67","author":"Dunlap","year":"1989","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0580","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tripleo.2004.08.021","article-title":"Bilateral central giant cell granulomas of the mandible in an 8-year-old girl with Noonan syndrome (Noonan-like\/multiple giant cell lesion syndrome)","volume":"99","author":"Edwards","year":"2005","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0585","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1399-0004.2009.01149.x","article-title":"SOS1: a new player in the Noonan-like\/multiple giant cell lesion syndrome","volume":"75","author":"Hanna","year":"2009","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0590","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1399-0004.2005.00475.x","article-title":"Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism","volume":"68","author":"Jafarov","year":"2005","journal-title":"Clin. Genet."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0595","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/ajmg.a.35493","article-title":"Case report: Noonan syndrome with multiple giant cell lesions and review of the literature","volume":"158A","author":"Karbach","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0600","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2004.024091","article-title":"Phenotypic and genotypic characterisation of Noonan-like\/multiple giant cell lesion syndrome","volume":"42","author":"Lee","year":"2005","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0605","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-263X.2005.00604.x","article-title":"Noonan syndrome with giant cell lesions","volume":"15","author":"Lee","year":"2005","journal-title":"Int. J. Paediatr. Dent."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0610","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/0278-2391(91)90069-X","article-title":"Cherubism in a patient with Noonan syndrome: report of a case","volume":"49","author":"Levine","year":"1991","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0615","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00247-016-3743-3","article-title":"Multifocal tenosynovial giant cell tumors in a child with Noonan syndrome","volume":"47","author":"Meyers","year":"2017","journal-title":"Pediatr. Radiol."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0620","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ejhg.2008.188","article-title":"Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome","volume":"17","author":"Neumann","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bone.2021.115935_bb0625","series-title":"Noonan syndrome with multiple giant cell lesions, management and treatment with surgery and interferon alpha-2a therapy: case report, Birth Defects Res","author":"Rodriguez","year":"2020"},{"key":"10.1016\/j.bone.2021.115935_bb0630","series-title":"Giant cell lesion of the jaw as a presenting feature of Noonan syndrome, BMJ Case Rep 2018","author":"Sinnott","year":"2018"},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb0635","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.joms.2006.04.025","article-title":"Noonan-like\/multiple giant cell lesion syndrome: report of a case and review of the literature","volume":"64","author":"Wolvius","year":"2006","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0640","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0278-2391(99)90833-9","article-title":"Bilateral central giant cell granulomas in a patient with neurofibromatosis: report of a case and review of the literature","volume":"57","author":"Ardekian","year":"1999","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0645","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jcms.2010.10.014","article-title":"Neurofibromatosis type 1 associated with bilateral central giant cell granuloma of the mandible","volume":"39","author":"Chrcanovic","year":"2011","journal-title":"J. Craniomaxillofac. Surg."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0650","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.tripleo.2005.10.038","article-title":"Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1","volume":"102","author":"Edwards","year":"2006","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.bone.2021.115935_bb0655","series-title":"Cherubism Associated With Neurofibromatosis Type 1, and Multiple Osteolytic Lesions of Both Femurs: A Previously Undescribed Association of Findings","author":"Martinez-Tello","year":"2005"},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0660","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00431-006-0334-6","article-title":"Neurofibromatosis presenting with a cherubism phenotype","volume":"166","author":"van Capelle","year":"2007","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0665","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0901-5027(05)80323-6","article-title":"Differentiation of multiple giant cell lesions, Noonan-like syndrome, and (occult) hyperparathyroidism. Case report and review of the literature","volume":"23","author":"van Damme","year":"1994","journal-title":"Int. J. Maxillofac. Surg."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0670","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/gim.2013.163","article-title":"Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder","volume":"16","author":"Stewart","year":"2014","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0675","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ajmg.1320250305","article-title":"Cherubism, gingival fibromatosis, epilepsy, and mental deficiency (Ramon syndrome) with juvenile rheumatoid arthritis","volume":"25","author":"Pina-Neto","year":"1986","journal-title":"Am. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0680","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12105-009-0155-9","article-title":"Cherubism combined with epilepsy, mental retardation and gingival fibromatosis (Ramon syndrome): a case report","volume":"4","author":"Suhanya","year":"2010","journal-title":"Head Neck Pathol."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0685","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13005-018-0171-7","article-title":"Bilateral central giant cell granuloma of the mandibular angle in three females from the same family","volume":"14","author":"Tecco","year":"2018","journal-title":"Head Face Med."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0690","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0030-4220(67)90416-1","article-title":"Gingival fibromatosis combined with cherubism","volume":"24","author":"Ramon","year":"1967","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0695","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1902\/jop.1999.70.2.201","article-title":"Gingival fibromatosis combined with cherubism and psychomotor retardation: a rare syndrome","volume":"70","author":"Yalcin","year":"1999","journal-title":"J. Periodontol."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0700","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4103\/jisp.jisp_318_13","article-title":"Cherubism with idiopathic gingival enlargement: a rare case report","volume":"21","author":"Elavarasu","year":"2017","journal-title":"J Indian Soc Periodontol"},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0705","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/cge.13166","article-title":"Homozygous mutation in ELMO2 may cause Ramon syndrome","volume":"93","author":"Mehawej","year":"2018","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0710","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00019605-199201000-00005","article-title":"Ramon syndrome with diabetes mellitus and vascular skin lesions in two sibs","volume":"1","author":"Pridmore","year":"1992","journal-title":"Clin. Dysmorphol."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb0715","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ajmg.a.31663","article-title":"Novel oral findings in Schimmelpenning syndrome","volume":"143A","author":"Ernst","year":"2007","journal-title":"Am. J. Med. Genet. A"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0720","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00019605-200404000-00005","article-title":"Oculo-ectodermal syndrome: a new tumour predisposition syndrome","volume":"13","author":"Federici","year":"2004","journal-title":"Clin. Dysmorphol."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0725","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00019605-199910000-00006","article-title":"Non-ossifying fibromas and giant cell reparative granulomas in a child with ocular-ectodermal syndrome","volume":"8","author":"Toriello","year":"1999","journal-title":"Clin. Dysmorphol."},{"key":"10.1016\/j.bone.2021.115935_bb0730","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00003086-198208000-00036","article-title":"Disseminated nonossifying fibromas in association with cafe-au-lait spots (Jaffe-Campanacci syndrome)","volume":"168","author":"Mirra","year":"1982","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0735","doi-asserted-by":"crossref","first-page":"731","DOI":"10.14219\/jada.archive.1988.0110","article-title":"Bilateral giant cell granulomata of the mandible: report of case","volume":"117","author":"Cassatly","year":"1988","journal-title":"J. Am. Dent. Assoc."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0740","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0301-0503(77)80089-1","article-title":"Multiple recurrent central giant cell granulomas of the jaws. Case report","volume":"5","author":"Davis","year":"1977","journal-title":"J. Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0745","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0266-4356(91)90092-J","article-title":"Multiple recurrent giant cell lesions associated with high circulating levels of parathyroid hormone-related peptide in a young adult","volume":"29","author":"Davis","year":"1991","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0750","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ijporl.2010.02.006","article-title":"Idiopathic bilateral central giant cell reparative granuloma of jaws: a case report and literature review","volume":"74","author":"Orhan","year":"2010","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0755","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0278-2391(90)90398-L","article-title":"Multifocal central giant cell lesions of the maxillofacial skeleton: a case report","volume":"48","author":"Smith","year":"1990","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0760","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/gcc.20735","article-title":"Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations","volume":"49","author":"Denayer","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0765","first-page":"90","article-title":"Unilateral giant cell lesion of the jaw in Noonan syndrome","volume":"97","author":"Eyselbergs","year":"2014","journal-title":"JBR-BTR"},{"issue":"4A","key":"10.1016\/j.bone.2021.115935_bb0770","first-page":"2079","article-title":"Loss of heterozygosity in tumor cells of a recurrent mandibular giant cell granuloma in neurofibromatosis type 1","volume":"27","author":"Friedrich","year":"2007","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0775","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0901-5027(05)80520-X","article-title":"Epidermal nevus syndrome with maxillary involvement","volume":"22","author":"Kaplan","year":"1993","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0780","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/08830738030180051901","article-title":"Neurofibromatosis 1: a novel NF1 mutation in an 11-year-old girl with a giant cell granuloma","volume":"18","author":"Krammer","year":"2003","journal-title":"J. Child Neurol."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0785","first-page":"77","article-title":"Oculoectodermal syndrome: a new case with giant cell granulomas and non-ossifying fibromas","volume":"27","author":"Mermer","year":"2016","journal-title":"Genet. Couns."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0790","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1079-2104(99)70297-0","article-title":"Unusual form of recurrent giant cell granuloma of the mandible and lower extremities in a patient with neurofibromatosis type 1","volume":"87","author":"Ruggieri","year":"1999","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0795","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1399-0004.1998.tb02756.x","article-title":"Noonan syndrome associated with central giant cell granuloma","volume":"53","author":"U\u00e7ar","year":"1998","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0800","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.0303-6987.2006.00374.x","article-title":"Intraoral lesions associated with sebaceous nevus syndrome","volume":"33","author":"Warnke","year":"2006","journal-title":"J. Cutan. Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0805","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.tripleo.2003.12.042","article-title":"A case of neurofibromatosis-Noonan syndrome with a central giant cell granuloma","volume":"98","author":"Yazdizadeh","year":"2004","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.bone.2021.115935_bb0810","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"R2","key":"10.1016\/j.bone.2021.115935_bb0815","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1093\/hmg\/ddw191","article-title":"Pathogenetics of the RASopathies","volume":"25","author":"Tidyman","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0820","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40142-016-0100-7","article-title":"Expansion of the RASopathies","volume":"4","author":"Tidyman","year":"2016","journal-title":"Curr. Genet. Med. Rep."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0825","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"issue":"4965","key":"10.1016\/j.bone.2021.115935_bb0830","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0835","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0840","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0845","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","article-title":"Germline gain-of-function mutations in SOS1 cause Noonan syndrome","volume":"39","author":"Roberts","year":"2007","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0850","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","article-title":"Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome","volume":"39","author":"Tartaglia","year":"2007","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb0855","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nature Genet"},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb0860","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0865","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0870","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb0875","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.497","article-title":"A restricted spectrum of NRAS mutations causes Noonan syndrome","volume":"42","author":"Cirstea","year":"2010","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0880","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.425","article-title":"Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair","volume":"41","author":"Cordeddu","year":"2009","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0885","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajhg.2010.06.015","article-title":"Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype","volume":"87","author":"Martinelli","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb0890","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng.641","article-title":"Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia","volume":"42","author":"Niemeyer","year":"2010","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb0895","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0900","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/humu.20955","article-title":"Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum","volume":"30","author":"Sarkozy","year":"2009","journal-title":"Hum. Mut."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb0905","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.20748","article-title":"The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders","volume":"29","author":"Aoki","year":"2008","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0910","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome","volume":"38","author":"Niihori","year":"2006","journal-title":"Nat. Genet."},{"issue":"5765","key":"10.1016\/j.bone.2021.115935_bb0915","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb0920","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jmg.2010.076836","article-title":"Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia","volume":"47","author":"Perez","year":"2010","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0925","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1086\/339689","article-title":"A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1","volume":"70","author":"Hart","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0930","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.ejhg.5200817","article-title":"Locus for susceptibility for familial capillary malformation (\u2018port-wine stain\u2019) maps to 5q","volume":"10","author":"Eerola","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2021.115935_bb0935","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ocr.12144","article-title":"A review of craniofacial and dental findings of the RASopathies","volume":"20","author":"Cao","year":"2017","journal-title":"Orthod. Craniofac. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0940","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1210\/er.2017-00232","article-title":"The RASopathy family: consequences of germline activation of the RAS\/MAPK pathway","volume":"39","author":"Tajan","year":"2018","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb0945","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","article-title":"The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation","volume":"19","author":"Tidyman","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0950","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1302\/0301-620X.65B5.6643569","article-title":"Multiple non-ossifying fibromata with extraskeletal anomalies: a new syndrome?","volume":"65","author":"Campanacci","year":"1983","journal-title":"J. Bone Joint Surg. Br."},{"issue":"24","key":"10.1016\/j.bone.2021.115935_bb0955","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/ajmg.a.31969","article-title":"Expanding the phenotype of oculoectodermal syndrome: possible relationship to encephalocraniocutaneous lipomatosis","volume":"143A","author":"Ardinger","year":"2007","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.bone.2021.115935_bb0960","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jmg.2009.066068","article-title":"Encephalocraniocutaneous lipomatosis","volume":"46","author":"Moog","year":"2009","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.625","article-title":"Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies","volume":"7","author":"Chacon-Camacho","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.bone.2021.115935_bb0970","series-title":"Am. J. Hum. Genet.","first-page":"579","article-title":"Mosaic activating mutations in FGFR1 cause encephalocraniocutaneous lipomatosis","volume":"98","author":"Bennett","year":"2016"},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb0975","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/cge.12775","article-title":"Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis","volume":"90","author":"Boppudi","year":"2016","journal-title":"Clin. Genet."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0980","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.2316","article-title":"Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome","volume":"44","author":"Groesser","year":"2012","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0985","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ajmg.a.37048","article-title":"Oculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterations","volume":"167","author":"Peacock","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb0990","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tig.2015.03.013","article-title":"Somatic mosaicism: implications for disease and transmission genetics","volume":"31","author":"Campbell","year":"2015","journal-title":"Trends Genet."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb0995","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/cge.12502","article-title":"Detecting somatic mosaicism: considerations and clinical implications","volume":"87","author":"Cohen","year":"2015","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1000","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/1346-8138.13153","article-title":"Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi","volume":"43","author":"Igawa","year":"2016","journal-title":"J. Dermatol."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb1005","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/ajmg.a.37135","article-title":"A postzygotic NRAS mutation in a patient with Schimmelpenning syndrome","volume":"167A","author":"Kuroda","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"issue":"47","key":"10.1016\/j.bone.2021.115935_bb1010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008016","article-title":"Somatic KRAS mutation in an infant with linear nevus sebaceous syndrome associated with lymphatic malformations: a case report and literature review","volume":"96","author":"Lihua","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1015","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/jid.2012.377","article-title":"Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome","volume":"133","author":"Sun","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bone.2021.115935_bb1020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12881-015-0247-1","article-title":"KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant","volume":"16","author":"Wang","year":"2015","journal-title":"BMC Med. Genet."},{"issue":"Suppl 1","key":"10.1016\/j.bone.2021.115935_bb1025","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1750-1172-7-S1-S5","article-title":"The role of SH3BP2 in the pathophysiology of cherubism","volume":"7","author":"Reichenberger","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.stomax.2009.09.006","volume":"110","author":"Brix","year":"2009","journal-title":"Rev. Stomatol. Chir. Maxillofac."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0039-1698923","article-title":"Treatment of cherubism with salmon calcitonin: a case report","volume":"5","author":"Etoz","year":"2011","journal-title":"Eur. J. Dent."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0030-4220(92)90137-F","article-title":"Cherubism: diagnosis, treatment, and comparison with central giant cell granulomas and giant cell tumors","volume":"73","author":"Kaugars","year":"1992","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"Suppl 1","key":"10.1016\/j.bone.2021.115935_bb1045","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1750-1172-7-S1-S6","article-title":"Cherubism: best clinical practice","volume":"7","author":"Papadaki","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00001665-200303000-00012","article-title":"Cherubism: clinical evidence and therapy","volume":"14","author":"Schultze-Mosgau","year":"2003","journal-title":"J. Craniofac. Surg."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1055","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1067\/moe.2000.108438","article-title":"Cherubism: a 36-year long-term follow-up of 2 generations in different families and review of the literature","volume":"90","author":"Von Wowern","year":"2000","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1060","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archopht.121.4.570","article-title":"Optic neuropathy and macular chorioretinal folds caused by orbital cherubism","volume":"121","author":"Ahmadi","year":"2003","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1442-9071.2001.00363.x","article-title":"Orbital involvement in cherubism","volume":"29","author":"Carroll","year":"2001","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb1070","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0161-6420(01)00757-6","article-title":"Orbital involvement in cherubism","volume":"108","author":"Colombo","year":"2001","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0278-2391(00)90069-7","article-title":"Aggressive form of cherubism: report of a case","volume":"58","author":"Timosca","year":"2000","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/thorax.58.6.552","article-title":"Sleep disordered breathing in an adult with cherubism","volume":"58","author":"Ladhani","year":"2003","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1302\/0301-620X.32B3.334","article-title":"Cherubism\u2014familial fibrous dysplasia of the jaws","volume":"32-B","author":"Jones","year":"1950","journal-title":"J Bone Joint Surg. Br."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1090","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2214\/ajr.182.4.1821051","article-title":"Imaging characteristics of cherubism","volume":"182","author":"Beaman","year":"2004","journal-title":"AJR Am. J. Roentgenol."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00349920","article-title":"The computed tomographic appearances of cherubism","volume":"16","author":"Bianchi","year":"1987","journal-title":"Skelet. Radiol."},{"issue":"11","key":"10.1016\/j.bone.2021.115935_bb1100","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0278-2391(98)90618-8","article-title":"Treatment of cherubism with locally aggressive behavior presenting in adulthood: report of four cases and a proposed new grading system","volume":"56","author":"Kalantar Motamedi","year":"1998","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0901-5027(88)80043-2","article-title":"Cherubism. Histo-enzymological and ultrastructural study","volume":"17","author":"Chomette","year":"1988","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1110","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijom.2004.09.006","article-title":"Clinicopathologic study of 24 cases of cherubism","volume":"34","author":"Meng","year":"2005","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1115","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.joms.2006.02.003","article-title":"Cherubism: a clinical, radiographic, and histopathologic comparison of 7 cases","volume":"64","author":"Penarrocha","year":"2006","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/modpathol.3880527","article-title":"Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws","volume":"15","author":"Regezi","year":"2002","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1125","first-page":"589","article-title":"Expression of c-Src and comparison of cytologic features in cherubism, central giant cell granuloma and giant cell tumors","volume":"15","author":"Wang","year":"2006","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s002560050530","article-title":"Cherubism: clinicopathologic features","volume":"28","author":"Yamaguchi","year":"1999","journal-title":"Skelet. Radiol."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0278-2391(91)90185-O","article-title":"Cherubism involving a mother and daughter: case reports and review of the literature","volume":"49","author":"Faircloth","year":"1991","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.bdj.4806369","article-title":"Cherubism: a report of a case with an unusual post-extraction complication","volume":"164","author":"Ireland","year":"1988","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.bone.2021.115935_bb1145","series-title":"Cherubism with Mmultiple dental abnormalities: a rare presentation, BMJ Case Rep 2014","author":"Misra","year":"2014"},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1150","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ijporl.2007.01.017","article-title":"Aggressive case of cherubism: 17-year follow-up","volume":"71","author":"Pontes","year":"2007","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejmg.2012.12.008","article-title":"Characterization of a Norwegian cherubism cohort; molecular genetic findings, oral manifestations and quality of life","volume":"56","author":"Prescott","year":"2013","journal-title":"Eur. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1601-0825.2001.70211.x","article-title":"Cherubism\u2014clinical picture and treatment","volume":"7","author":"Kozakiewicz","year":"2001","journal-title":"Oral Dis."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/1096-8628(20001211)95:4<325::AID-AJMG6>3.0.CO;2-R","article-title":"Craniosynostosis in cherubism","volume":"95","author":"Stiller","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0007-117X(78)80055-9","article-title":"Cherubism: a report on three cases","volume":"16","author":"Wayman","year":"1978","journal-title":"Br. J. Oral Surg."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb1175","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1054\/bjps.2001.3701","article-title":"Cherubism and its charlatans","volume":"54","author":"Lannon","year":"2001","journal-title":"Br. J. Plast. Surg."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1180","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/SCS.0b013e3181ecc529","article-title":"Postpubertal nonfamilial cherubism and teeth transposition","volume":"21","author":"Ozan","year":"2010","journal-title":"J. Craniofac. Surg."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1185","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.oooo.2012.01.031","article-title":"A novel c.1255G>T (p.D419Y) mutation in SH3BP2 gene causes cherubism in a Turkish family","volume":"114","author":"Dinckan","year":"2012","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0007-117X(78)80054-7","article-title":"Cherubism\u2014an initial unilateral presentation","volume":"16","author":"Arnott","year":"1978","journal-title":"Br. J. Oral Surg."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1195","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/01.sap.0000248141.36904.19","article-title":"Two-stage surgical treatment of severe cherubism","volume":"58","author":"Raposo-Amaral","year":"2007","journal-title":"Ann. Plast. Surg."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb1200","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0030-4220(57)80047-4","article-title":"Cherubism","volume":"10","author":"Seward","year":"1957","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijom.2008.10.010","article-title":"Familial cherubism: the experience of the Moscow Central Institute for Stomatology and Maxillo-Facial Surgery","volume":"38","author":"Roginsky","year":"2009","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2021.115935_bb1210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2016.07.019","article-title":"Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism","volume":"58","author":"Kadlub","year":"2016","journal-title":"Hum. Pathol."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb1215","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/odi.12705","article-title":"Clinical and genetic analysis of patients with cherubism","volume":"23","author":"Machado","year":"2017","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/302454","article-title":"The gene for cherubism maps to chromosome 4p16.3","volume":"65","author":"Mangion","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1225","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/302456","article-title":"Raposo do Amaral C.M., Olsen B.R., The gene for cherubism maps to chromosome 4p16","volume":"65","author":"Tiziani","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/88832","article-title":"Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism","volume":"28","author":"Ueki","year":"2001","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1601-0825.2008.01499.x","article-title":"Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism","volume":"15","author":"Carvalho","year":"2009","journal-title":"Oral Dis."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.oraloncology.2007.01.012","article-title":"A novel mutation of the SH3BP2 gene in an aggressive case of cherubism","volume":"44","author":"Carvalho","year":"2008","journal-title":"Oral Oncol."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1245","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.tripleo.2007.04.003","article-title":"Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options","volume":"104","author":"de Lange","year":"2007","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1250","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1597\/1545-1569_2003_040_0632_ammits_2.0.co_2","article-title":"A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism","volume":"40","author":"Imai","year":"2003","journal-title":"Cleft Palate Craniofac. J."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1255","first-page":"209","article-title":"Investigation of the SH3BP2 gene mutation in cherubism","volume":"62","author":"Lee","year":"2008","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.bone.2021.115935_bb1260","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2350-7-84","article-title":"A novel mutation in the SH3BP2 gene causes cherubism: case report","volume":"7","author":"Li","year":"2006","journal-title":"BMC Med. Genet."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1265","first-page":"368","article-title":"[Mutation detection in SH3BP2 gene in a cherubism family]","volume":"41","author":"Li","year":"2006","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajmg.a.20226","article-title":"Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism","volume":"121A","author":"Lo","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000314268","article-title":"Identical mutation in SH3BP2 gene causes clinical phenotypes with different severity in mother and daughter - case report","volume":"1","author":"Preda","year":"2010","journal-title":"Mol. Syndromol."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1280","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/cga.12013","article-title":"Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism","volume":"53","author":"Sangu","year":"2013","journal-title":"Congenit. Anom. (Kyoto)"},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1285","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.4317\/medoral.19496","article-title":"A c.1244G>A (p.Arg415Gln) mutation in SH3BP2 gene causes cherubism in a Turkish family: report of a family with review of the literature","volume":"19","author":"Sekerci","year":"2014","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1290","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0278-2391(10)80276-9","article-title":"Cherubism: report of an aggressive case and review of the literature","volume":"51","author":"Ayoub","year":"1993","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1295","doi-asserted-by":"crossref","first-page":"455","DOI":"10.14219\/jada.archive.1985.0112","article-title":"Cherubism: report of a nonfamilial case","volume":"111","author":"DeTomasi","year":"1985","journal-title":"J. Am. Dent. Assoc."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb1300","first-page":"632","article-title":"Non familial cherubism: report of two cases","volume":"31","author":"Grunebaum","year":"1973","journal-title":"J. Oral Surg."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb1305","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.bbamcr.2007.01.012","article-title":"Ras oncogenes and their downstream targets","volume":"1773","author":"Rajalingam","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1315","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1083\/jcb.201609124","article-title":"Spatial and temporal signal processing and decision making by MAPK pathways","volume":"216","author":"Atay","year":"2017","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1320","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/1096-8628(20000918)94:3<254::AID-AJMG13>3.0.CO;2-7","article-title":"Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome","volume":"94","author":"Zollino","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1325","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1182\/blood-2003-08-2965","article-title":"The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor","volume":"105","author":"Foucault","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb1330","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1074\/jbc.M209509200","article-title":"The chaperone protein 14-3-3 interacts with 3BP2\/SH3BP2 and regulates its adapter function","volume":"278","author":"Foucault","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1335","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1074-7613(00)80657-3","article-title":"Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation","volume":"9","author":"Deckert","year":"1998","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb1340","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/bi048353o","article-title":"Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor","volume":"44","author":"Qu","year":"2005","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1345","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.febslet.2007.01.084","article-title":"Abl-SH3 binding protein 2, 3BP2, interacts with CIN85 and HIP-55","volume":"581","author":"Le Bras","year":"2007","journal-title":"FEBS Lett."},{"issue":"5098","key":"10.1016\/j.bone.2021.115935_bb1350","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.8438166","article-title":"Identification of a ten-amino acid proline-rich SH3 binding site","volume":"259","author":"Ren","year":"1993","journal-title":"Science"},{"issue":"5071","key":"10.1016\/j.bone.2021.115935_bb1355","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.1379745","article-title":"Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho","volume":"257","author":"Cicchetti","year":"1992","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1360","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2011.10.045","article-title":"Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism","volume":"147","author":"Levaot","year":"2011","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb1365","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.4049\/jimmunol.166.12.7219","article-title":"Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2","volume":"166","author":"Jevremovic","year":"2001","journal-title":"J. Immunol."},{"issue":"27","key":"10.1016\/j.bone.2021.115935_bb1370","doi-asserted-by":"crossref","first-page":"24912","DOI":"10.1074\/jbc.M301201200","article-title":"Adaptor protein 3BP2 is a potential ligand of Src homology 2 and 3 domains of Lyn protein-tyrosine kinase","volume":"278","author":"Maeno","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2021.115935_bb1375","series-title":"Oncogenes","author":"Cooper","year":"1995"},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1380","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cell.2006.10.047","article-title":"Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 \u201ccherubism\u201d mice","volume":"128","author":"Ueki","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1385","doi-asserted-by":"crossref","first-page":"140.e1","DOI":"10.1016\/j.ajodo.2009.05.021","article-title":"Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function","volume":"138","author":"Mukherjee","year":"2010","journal-title":"Am. J. Orthod. Dentofacial Orthop."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1390","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2006.12.019","article-title":"Jawing about TNF: new hope for cherubism","volume":"128","author":"Novack","year":"2007","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb1395","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1172\/JCI26132","article-title":"M-CSF mediates TNF-induced inflammatory osteolysis","volume":"115","author":"Kitaura","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.bone.2021.115935_bb1400","doi-asserted-by":"crossref","first-page":"11846","DOI":"10.1074\/jbc.M512624200","article-title":"Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression","volume":"281","author":"Yao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2021.115935_bb1405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","article-title":"Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology","volume":"321","author":"Nanes","year":"2003","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1410","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1677\/JOE-08-0568","article-title":"Bone loss in inflammatory disorders","volume":"201","author":"Hardy","year":"2009","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1415","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1074\/jbc.M008198200","article-title":"Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways","volume":"276","author":"Zhang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1420","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","article-title":"Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis","volume":"30","author":"Romas","year":"2002","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1425","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/BOR.0b013e32825f5492","article-title":"Autoinflammatory bone disorders","volume":"19","author":"Ferguson","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bone.2021.115935_bb1430","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease","volume":"27","author":"Masters","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1435","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbrc.2008.04.080","article-title":"SH3BP2 is an activator of NFAT activity and osteoclastogenesis","volume":"371","author":"Lietman","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"27","key":"10.1016\/j.bone.2021.115935_bb1440","doi-asserted-by":"crossref","first-page":"20952","DOI":"10.1074\/jbc.M109.091124","article-title":"3BP2 adapter protein is required for receptor activator of NFkappaB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells","volume":"285","author":"GuezGuez","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bone.2021.115935_bb1445","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1172\/JCI35711","article-title":"NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism","volume":"118","author":"Aliprantis","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb1450","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1074\/jbc.M311687200","article-title":"Sensitization of epidermal growth factor-induced signaling by bradykinin is mediated by c-Src. Implications for a role of lipid microdomains","volume":"279","author":"Hur","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bone.2021.115935_bb1455","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/jor.21164","article-title":"SH3BP2 mutations potentiate osteoclastogenesis via PLCgamma","volume":"28","author":"Lietman","year":"2010","journal-title":"J. Orthop. Res."},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb1460","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/jbmr.2295","article-title":"SH3BP2 cherubism mutation potentiates TNF-alpha-induced osteoclastogenesis via NFATc1 and TNF-alpha-mediated inflammatory bone loss","volume":"29","author":"Mukai","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb1465","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1470","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1475","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1480","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.20050978","article-title":"Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis","volume":"202","author":"Kim","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1485","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.cell.2011.10.046","article-title":"Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease","volume":"147","author":"Guettler","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1490","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cell.2011.11.035","article-title":"Tankyrase loses its grip on SH3BP2 in cherubism","volume":"147","author":"Berendsen","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bone.2021.115935_bb1495","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bone.2017.10.017","article-title":"Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis","volume":"106","author":"Fujita","year":"2018","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1500","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrm3254","article-title":"Building strong bones: molecular regulation of the osteoblast lineage","volume":"13","author":"Long","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bone.2021.115935_bb1505","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.cellbio.16.1.191","article-title":"Bone development","volume":"16","author":"Olsen","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1510","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/157488808784223032","article-title":"Differentiation of osteoblasts and osteocytes from mesenchymal stem cells","volume":"3","author":"Heino","year":"2008","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"6937","key":"10.1016\/j.bone.2021.115935_bb1515","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature01660","article-title":"Control of osteoblast function and regulation of bone mass","volume":"423","author":"Harada","year":"2003","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.bone.2021.115935_bb1520","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1038\/sj.onc.1207676","article-title":"Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression","volume":"23","author":"Stein","year":"2004","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb1525","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.biocel.2007.05.024","article-title":"Runx2: of bone and stretch","volume":"40","author":"Ziros","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1530","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1535","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.abb.2008.02.030","article-title":"Transcription factors controlling osteoblastogenesis","volume":"473","author":"Marie","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1540","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1545","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/edrv.21.4.0403","article-title":"Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1","volume":"21","author":"Yamaguchi","year":"2000","journal-title":"Endocr. Rev."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb1550","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1172\/JCI45843","article-title":"3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions","volume":"121","author":"Levaot","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"23","key":"10.1016\/j.bone.2021.115935_bb1555","doi-asserted-by":"crossref","first-page":"13298","DOI":"10.1073\/pnas.2336149100","article-title":"Src kinase activation by direct interaction with the integrin beta cytoplasmic domain","volume":"100","author":"Arias-Salgado","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb1560","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1172\/JCI87802","article-title":"Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2","volume":"126","author":"Matsumoto","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1565","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bone.2010.01.380","article-title":"Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties","volume":"46","author":"Wang","year":"2010","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb1570","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/jbmr.5650110910","article-title":"Signal transduction by basic fibroblast growth factor in rat osteoblastic Py1a cells","volume":"11","author":"Hurley","year":"1996","journal-title":"J. Bone Miner. Res."},{"issue":"39","key":"10.1016\/j.bone.2021.115935_bb1575","doi-asserted-by":"crossref","first-page":"36181","DOI":"10.1074\/jbc.M206057200","article-title":"Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1\/Runx2","volume":"277","author":"Xiao","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.bone.2021.115935_bb1580","doi-asserted-by":"crossref","first-page":"29121","DOI":"10.1074\/jbc.M313000200","article-title":"Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"46","key":"10.1016\/j.bone.2021.115935_bb1585","doi-asserted-by":"crossref","first-page":"29309","DOI":"10.1074\/jbc.272.46.29309","article-title":"Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells","volume":"272","author":"Takeuchi","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bone.2021.115935_bb1590","doi-asserted-by":"crossref","first-page":"13365","DOI":"10.1074\/jbc.M009846200","article-title":"Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts","volume":"276","author":"You","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1595","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1083\/jcb.200610046","article-title":"Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development","volume":"176","author":"Ge","year":"2007","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb1600","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1359\/jbmr.060603","article-title":"Ras-MAPK signaling in osteogenic differentiation: friend or foe?","volume":"21","author":"Schindeler","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1359\/jbmr.2002.17.1.101","article-title":"Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells","volume":"17","author":"Xiao","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1610","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1074\/jbc.275.6.4453","article-title":"MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1","volume":"275","author":"Xiao","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1615","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jcb.20087","article-title":"Differential effects of PD98059 and U0126 on osteogenesis and adipogenesis","volume":"92","author":"Dang","year":"2004","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1620","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1006\/bbrc.2000.2210","article-title":"Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1\/2","volume":"268","author":"Lou","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.bone.2021.115935_bb1625","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.1074\/jbc.275.13.9645","article-title":"Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase","volume":"275","author":"Jaiswal","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1630","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1006\/bbrc.2001.5654","article-title":"Physical shock wave mediates membrane hyperpolarization and Ras activation for osteogenesis in human bone marrow stromal cells","volume":"287","author":"Wang","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"21","key":"10.1016\/j.bone.2021.115935_bb1635","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1128\/MCB.01549-08","article-title":"Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis","volume":"29","author":"Matsushita","year":"2009","journal-title":"Mol. Cell. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2021.115935_bb1640","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/03008200390152188","article-title":"Multiple signaling pathways converge on the Cbfa1\/Runx2 transcription factor to regulate osteoblast differentiation","volume":"44","author":"Franceschi","year":"2003","journal-title":"Connect. Tissue Res."},{"issue":"17","key":"10.1016\/j.bone.2021.115935_bb1645","doi-asserted-by":"crossref","first-page":"14443","DOI":"10.1074\/jbc.M010021200","article-title":"Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells","volume":"276","author":"Lai","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb1650","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1359\/jbmr.2001.16.10.1772","article-title":"Focal adhesion kinase activity is required for bone morphogenetic protein\u2014Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells","volume":"16","author":"Tamura","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"49","key":"10.1016\/j.bone.2021.115935_bb1655","doi-asserted-by":"crossref","first-page":"32988","DOI":"10.1074\/jbc.273.49.32988","article-title":"Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor","volume":"273","author":"Xiao","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1660","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1359\/jbmr.2003.18.5.827","article-title":"Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells","volume":"18","author":"Nakayama","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb1665","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1359\/jbmr.2002.17.10.1785","article-title":"Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix","volume":"17","author":"Higuchi","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1670","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/en.2002-220863","article-title":"Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation","volume":"144","author":"Hu","year":"2003","journal-title":"Endocrinology"},{"issue":"18","key":"10.1016\/j.bone.2021.115935_bb1675","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.biomaterials.2003.11.024","article-title":"Osteoblast proliferation and maturation by bisphosphonates","volume":"25","author":"Im","year":"2004","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1680","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bone.2003.08.013","article-title":"The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro","volume":"34","author":"Pan","year":"2004","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1685","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1006\/bbrc.2000.4232","article-title":"Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells","volume":"280","author":"Maeda","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1690","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S8756-3282(03)00239-4","article-title":"Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1\/Runx2 expression in bone marrow mesenchymal cell cultures","volume":"33","author":"Li","year":"2003","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1695","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2006.07.024","article-title":"Erk pathways negatively regulate matrix mineralization","volume":"40","author":"Kono","year":"2007","journal-title":"Bone"},{"issue":"6651","key":"10.1016\/j.bone.2021.115935_bb1700","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/39348","article-title":"Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1","volume":"389","author":"Kretzschmar","year":"1997","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb1705","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1101\/gad.13.7.804","article-title":"A mechanism of repression of TGFbeta\/Smad signaling by oncogenic Ras","volume":"13","author":"Kretzschmar","year":"1999","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1710","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bone.2005.01.022","article-title":"Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning","volume":"36","author":"Yu","year":"2005","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb1715","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Multiple roles for neurofibromin in skeletal development and growth","volume":"16","author":"Kolanczyk","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb1720","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00198-004-1801-4","article-title":"Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body","volume":"16","author":"Kuorilehto","year":"2005","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb1725","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-005-1940-2","article-title":"Decreased bone mineral density in patients with neurofibromatosis 1","volume":"16","author":"Lammert","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.115935_bb1730","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-cellbio-101512-122347","article-title":"Mitogen-activated protein kinase pathways in osteoblasts","volume":"29","author":"Greenblatt","year":"2013","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb1735","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103004","article-title":"Roles of mitogen-activated protein kinases in osteoclast biology","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1740","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3892\/ijmm.2015.2330","article-title":"Inhibition of RANKL-induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium-particle-induced osteolysis","volume":"36","author":"Li","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1745","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S8756-3282(01)00657-3","article-title":"The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation","volume":"30","author":"Lee","year":"2002","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2021.115935_bb1750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024780","article-title":"Erk1 positively regulates osteoclast differentiation and bone resorptive activity","volume":"6","author":"He","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V75.1.1.bloodjournal7511","article-title":"Colony-stimulating factor-1 receptor","volume":"75","author":"Sherr","year":"1990","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bone.2021.115935_bb1760","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/sj.onc.1201518","article-title":"Identification of a second Grb2 binding site in the v-Fms tyrosine kinase","volume":"15","author":"Mancini","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2021.115935_bb1765","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.0105-2896.2005.00331.x","article-title":"alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology","volume":"208","author":"Ross","year":"2005","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1770","first-page":"204","article-title":"Osteoclastogenesis\u2014current knowledge and future perspectives","volume":"8","author":"Yavropoulou","year":"2008","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"52","key":"10.1016\/j.bone.2021.115935_bb1775","doi-asserted-by":"crossref","first-page":"49343","DOI":"10.1074\/jbc.M103642200","article-title":"Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK","volume":"276","author":"Lee","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6717","key":"10.1016\/j.bone.2021.115935_bb1780","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1785","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1790","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0014-4827(03)00288-X","article-title":"Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation","volume":"289","author":"Kim","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bone.2021.115935_bb1795","series-title":"The Biology of Cancer","first-page":"175","article-title":"Cytoplasmic signaling circuitry programs many of the traits of cancer","author":"Weinberg","year":"2014"},{"issue":"3","key":"10.1016\/j.bone.2021.115935_bb1800","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.febslet.2004.12.066","article-title":"Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE\/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways","volume":"579","author":"Takami","year":"2005","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1805","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41467-018-03720-z","article-title":"Somatic activating mutations in MAP2K1 cause melorheostosis","volume":"9","author":"Kang","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1810","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/bloodadvances.2016001784","article-title":"The clinical spectrum of Erdheim-Chester disease: an observational cohort study","volume":"1","author":"Estrada-Veras","year":"2017","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1815","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.5216","article-title":"Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone","volume":"248","author":"Baumhoer","year":"2019","journal-title":"J. Pathol."},{"issue":"19","key":"10.1016\/j.bone.2021.115935_bb1820","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1825","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/path.5259","article-title":"Non-ossifying fibroma: a RAS-MAPK driven benign bone neoplasm","volume":"248","author":"Bovee","year":"2019","journal-title":"J. Pathol."},{"issue":"19","key":"10.1016\/j.bone.2021.115935_bb1830","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1074\/jbc.M116.716464","article-title":"Transient receptor potential vanilloid 4 ion channel functions as a pruriceptor in epidermal keratinocytes to evoke histaminergic itch","volume":"291","author":"Chen","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb1835","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.pain.2013.04.004","article-title":"Temporomandibular joint pain: a critical role for Trpv4 in the trigeminal ganglion","volume":"154","author":"Chen","year":"2013","journal-title":"Pain"},{"issue":"22","key":"10.1016\/j.bone.2021.115935_bb1840","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2021.115935_bb1845","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.critrevonc.2017.02.018","article-title":"FGFR a promising druggable target in cancer: molecular biology and new drugs","volume":"113","author":"Porta","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1850","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0896-6273(94)90438-3","article-title":"Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras","volume":"12","author":"Rosen","year":"1994","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.bone.2021.115935_bb1855","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0092-8674(00)00210-5","article-title":"TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2\/ERK-dependent pathway","volume":"103","author":"Dumitru","year":"2000","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bone.2021.115935_bb1860","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrm1743","article-title":"Coordinating ERK\/MAPK signalling through scaffolds and inhibitors","volume":"6","author":"Kolch","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.bone.2021.115935_bb1865","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1365-2443.2004.00784.x","article-title":"Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function","volume":"9","author":"Miah","year":"2004","journal-title":"Genes Cells"},{"issue":"14","key":"10.1016\/j.bone.2021.115935_bb1870","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1128\/MCB.00087-06","article-title":"3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation","volume":"26","author":"de la Fuente","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bone.2021.115935_bb1875","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/0-387-34132-3_8","article-title":"The adapter 3BP2: how it plugs into leukocyte signaling","volume":"584","author":"Deckert","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"issue":"16","key":"10.1016\/j.bone.2021.115935_bb1880","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1073\/pnas.1633695100","article-title":"A Ras activation pathway dependent on Syk phosphorylation of protein kinase C","volume":"100","author":"Kawakami","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1885","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4049\/jimmunol.173.2.1066","article-title":"TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-kappaB activation, and apoptosis","volume":"173","author":"Takada","year":"2004","journal-title":"J. ImmunoI."},{"issue":"10","key":"10.1016\/j.bone.2021.115935_bb1890","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ejmg.2015.08.005","article-title":"SHP2 sails from physiology to pathology","volume":"58","author":"Tajan","year":"2015","journal-title":"Eur. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1895","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00204-013-1035-3","article-title":"Mechanisms of RAS\/beta-catenin interactions","volume":"87","author":"Zeller","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1900","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1038\/s41467-020-19555-6","article-title":"MEKK2 mediates aberrant ERK activation in neurofibromatosis type I","volume":"11","author":"Bok","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1905","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.celrep.2014.08.023","article-title":"Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism","volume":"8","author":"Yoshitaka","year":"2014","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb1910","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1915","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger","volume":"8","author":"Kono","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1920","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/path.2284","article-title":"Macrophage activation by endogenous danger signals","volume":"214","author":"Zhang","year":"2008","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1925","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1930","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling","volume":"7","author":"O\u2019Neill","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1935","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.immuni.2012.10.014","article-title":"Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly","volume":"37","author":"Kollmann","year":"2012","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb1940","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nri3547","article-title":"Age-dependent dysregulation of innate immunity","volume":"13","author":"Shaw","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bone.2021.115935_bb1945","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.semcdb.2005.06.007","article-title":"Specification of neural crest cell formation and migration in mouse embryos","volume":"16","author":"Trainor","year":"2005","journal-title":"Semin. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1950","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0306-4522(96)00084-X","article-title":"Ras p21 protein promotes survival and differentiation of human embryonic neural crest-derived cells","volume":"73","author":"Borasio","year":"1996","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.bone.2021.115935_bb1955","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00418-015-1358-7","article-title":"Expression profile of critical genes involved in FGF signaling pathway in the developing human primary dentition","volume":"144","author":"Huang","year":"2015","journal-title":"Histochem. Cell Biol."},{"issue":"26","key":"10.1016\/j.bone.2021.115935_bb1960","doi-asserted-by":"crossref","first-page":"14444","DOI":"10.1073\/pnas.97.26.14444","article-title":"Evolutionary modification of development in mammalian teeth: quantifying gene expression patterns and topography","volume":"97","author":"Jernvall","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb1965","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1177\/0022034517717255","article-title":"Ras Signaling regulates stem cells and amelogenesis in the mouse incisor","volume":"96","author":"Zheng","year":"2017","journal-title":"J. Dent. Res."},{"issue":"6290","key":"10.1016\/j.bone.2021.115935_bb1970","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/347291a0","article-title":"Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway","volume":"347","author":"Buchberg","year":"1990","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1975","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(90)90151-4","article-title":"The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins","volume":"63","author":"Ballester","year":"1990","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bone.2021.115935_bb1980","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcms.2004.07.006","article-title":"Cherubism - new hypotheses on pathogenesis and therapeutic consequences","volume":"33","author":"Hyckel","year":"2005","journal-title":"J. Craniomaxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1985","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/10454411990100040401","article-title":"Actions of hedgehog proteins on skeletal cells","volume":"10","author":"Iwamoto","year":"1999","journal-title":"Crit. Rev. Oral Biol. Med."},{"issue":"4","key":"10.1016\/j.bone.2021.115935_bb1990","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/74231","article-title":"Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation","volume":"24","author":"Satokata","year":"2000","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.115935_bb1995","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2008-1033789","article-title":"Cherubismus - eine osteofibr\u00f6se kiefererkrankung im kindesalter","volume":"194","author":"Hoyer","year":"1982","journal-title":"Klin. Padiatr."},{"issue":"12","key":"10.1016\/j.bone.2021.115935_bb2000","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.ejhg.5201290","article-title":"A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigenes\/LEOPARD syndrome and Noonan-like\/multiple giant cell lesion syndrome","volume":"12","author":"Sarkozy","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.bone.2021.115935_bb2005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0278-2391(82)90016-7","article-title":"Multiple giant cell lesions of the jaws","volume":"40","author":"Weldon","year":"1982","journal-title":"J. Oral Maxillofac. Surg."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:56:21Z","timestamp":1757613381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":401,"alternative-id":["S8756328221000971"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.115935","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple versus solitary giant cell lesions of the jaw: Similar or distinct entities?","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.115935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115935"}}